# Lantheus Holdings, Inc. – Consensus ‘strong_buy’ rating and 45.6% Upside Potential

- Link: https://www.directorstalkinterviews.com/lantheus-holdings-inc-consensus-strong-buy-rating-and-45-6-upside-potential/4121185366
- Published: 2025-01-31T12:01:47+00:00
- Author: Charlotte Edwards

**Lantheus Holdings, Inc.** with ticker code (LNTH) now have 13 analysts in total
covering the stock. The consensus rating is pointing to ‘strong_buy’. The range 
between the high target price and low target price is between $166.00 and $110.00
calculating the mean target price we have $134.69. Given that the stocks previous
close was at $92.53 and the analysts are correct then there would likely be a percentage
uptick in value of 45.6%. The 50 day moving average now sits at $90.77 and the 200
day MA is $93.27. The market cap for the company is 6.45B. Currently the stock stands
at: $92.79 USD

 The potential market cap would be $9,391,038,870 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 15.41, revenue per share of $21.69
and a 17% return on assets.

Lantheus Holdings, Inc. is an integrated provider of imaging diagnostics, targeted
therapeutics, and artificial intelligence solutions to find, fight and follow serious
medical conditions. The Company’s products include precision diagnostics, radiopharmaceutical
oncology, and strategic partnerships. Its precision diagnostic products assist healthcare
professionals (HCPs) Find and Follow diseases, with a focus on cardiology. Its radiopharmaceutical
oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Its
strategic partnerships focus on enabling precision medicine through the use of biomarkers,
digital solutions and pharma services platforms, and also includes the Company’s
license of RELISTOR to Bausch Health Companies, Inc. (Bausch). Its commercial products
are used by oncologists, urologists, nuclear medicine physicians, cardiologists,
sonographers, technologists, radiologists, and internal medicine physicians working
in a variety of clinical settings.

Share on:
